How have DRUG and MASS total returns compared?

Over the past 5 years, DRUG delivered 6.76% and MASS delivered -17.66% annualized total return. Past performance doesn't predict future results.

Bright Minds Biosciences Inc. (DRUG) vs 908 Devices Inc. (MASS)

A side-by-side comparison of Bright Minds Biosciences Inc. and 908 Devices Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DRUG

Bright Minds Biosciences Inc.

$480M

$49.00HealthcareDelayed quote: Oct 6, 2026, 11:44 AM EDT

MASS

908 Devices Inc.

$516M

$12.57HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT

Total return — DRUG vs MASS

growth of $100 · dividends reinvested · last 6y

DRUG +84.4% (+10.7%/yr)MASS -75.0% (-20.7%/yr)DRUG compounded faster over this window

Log scale — wide-divergence pair

DRUG MASS

DRUG vs MASS: by the numbers

•MASS is the larger company ($516M vs $480M market cap).
•Both run net losses; DRUG's is the smaller (0.00% vs -56.68% net margin).

Metrics side by side

Valuation

Metric	DRUG	MASS
P/S ratio	N/A	8.48
P/B ratio	2.21	4.07
FCF yield	N/A	0.09%

Profitability

Metric	DRUG	MASS
Gross margin	0.00%	49.79%
Operating margin	0.00%	-46.01%
Net margin	0.00%	-56.68%
ROE	-8.21%	-27.20%
ROIC	-13.15%	-18.90%

Growth (annualized)

Metric	DRUG	MASS
Revenue CAGR (5Y)	N/A	18.92%
Total return CAGR (5Y)	6.76%	-17.66%

Frequently asked

How have DRUG and MASS total returns compared?: Over the past 5 years, DRUG delivered 6.76% and MASS delivered -17.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DRUG analysis Full MASS analysis Interactive comparison tool

Dig into the metrics

Bright Minds Biosciences ROE 908 Devices ROE Bright Minds Biosciences operating margin 908 Devices operating margin Bright Minds Biosciences revenue growth 908 Devices revenue growth Bright Minds Biosciences free cash flow 908 Devices free cash flow

Bright Minds Biosciences & 908 Devices appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.